NCT03948737View on ClinicalTrials.gov

The Effect of Alpha-tocopherol in Hemolysis and Oxidative Stress Marker on the Red Cell Membrane Beta-thalassemia Major

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 30, 2016

Primary Completion Date

July 30, 2017

Study Completion Date

August 1, 2017

Conditions

Beta Thalassemia Major AnemiaHemolysisOxidative Stress

Interventions

DRUG

Alpha-Tocopherol

all of the subjects in the alpha-tocopherol group received alpha-tocopherol orally, doses adjusted by age for 4 weeks of treatment.

DRUG

Placebo oral tablet

Trial Locations (1)

10340

Thalassemia Centre Kiara RSUP Dr.CiptoMangunkusumo, Jakarta Pusat

All Listed Sponsors

lead

Indonesia University

OTHER

NCT03948737 - The Effect of Alpha-tocopherol in Hemolysis and Oxidative Stress Marker on the Red Cell Membrane Beta-thalassemia Major | Biotech Hunter | Biotech Hunter